Reports for TRISENOX

Brand name
TRISENOX

Company Name

TEVA CANADA LIMITED

Drug Identification Number

02407833

Ingredients & Strength

Anatomical Therapeutical Chemical (ATC) Code

  • L01XX
  • L01XX

Anatomical Therapeutical Chemical (ATC) Descriptor

  • OTHER ANTINEOPLASTIC AGENTS
  • OTHER ANTINEOPLASTIC AGENTS

Status

CANCELLED POST MARKET
Shortage reports
Brand name Packaging size Status Date Created Date Updated Reports
TRISENOX 10 mg/10mL ampoule Resolved 2017-07-14 2018-07-30 15753
TRISENOX 1 Actual shortage 2020-05-14 2026-03-05 115216

Showing 1 to 2 of 2

Discontinuation reports
Brand name Packaging size Status Date Created Date Updated Reports

Showing 1 to 0 of 0